Vaccination

Vaccination is the administration of antigenic material to produce immunity to a disease. Vaccines can prevent or ameliorate the effects of infection by a pathogen. The material administrated can either be live, but weakened forms of pathogens such as bacteria or viruses, killed or inactivated forms of these pathogens, or purified material such as proteins. Smallpox was the first disease people tried to prevent by purposely inoculating themselves with other types of infections; smallpox inoculation was started in India or China before 200 BC. In 1718, Lady Mary Wortley Montague reported that the Turks have a habit of deliberately inoculating themselves with fluid taken from mild cases of smallpox and she inoculated her own children.Before Edward Jenner tested the possibility of using the cowpox vaccine as an immunisation for smallpox in humans in 1796 for the first time, at least six people have done the same several years earlier: a person whose identity is unknown, England, , Mrs. Sevel, Germany , Mr. Jensen, Germany , Benjamin Jesty, England, in 1774, Mrs. Rendall, England and Peter Plett, Germany, in 1791. In 1796 Edward Jenner inoculated using cowpox . Pasteur and others built on this. Vaccination efforts have been met with some controversy since their inception, on ethical, political, medical safety, religious, and other grounds. Early success and compulsion brought widespread acceptance and mass vaccination campaigns were undertaken which are credited with greatly reducing the incidence of many diseases in numerous geographic regions. The eradication of smallpox, which was last seen in a natural case in 1977, is considered the most evident success of vaccination. (From the Wikpedia article Vaccination.)

Download PDF

Recent Publications on Vaccination:
Survey of prophylactic antibiotic use amongst UK cochlear implant surgeons. Cochlear implant patients are at an increased risk of pneumococcal...	12th July, 2008	South of England Cochlear Implant Centre, Institute of Sound and Vibration	Cochlear Implants Int. 2008 Jul 10;. DOI Direct Link
Effectiveness of a vaccination program against mumps in Ukraine. Medical records and incidence data were analyzed retrospectively to...	12th July, 2008	Department of Pediatric Infectious Diseases, Lviv National Medical	Eur J Clin Microbiol Infect Dis. 2008 Jul 11;. DOI Direct Link
Dendritic cell vaccination and immune monitoring. We exploited dendritic cells (DC) to vaccinate melanoma patients. We...	12th July, 2008	Department of Medical Oncology, Nijmegen Centre for Molecular Life	Cancer Immunol Immunother. 2008 Jul 10;. DOI Direct Link
Preparing for an influenza pandemic in singapore. The national strategy against pandemic influenza essentially consists of 3...	12th July, 2008	Ministry of Health, Singapore.	Ann Acad Med Singapore. 2008 Jun;37(6):497-7.
The efficacy of influenza vaccination in healthcare workers in a tropical setting: a prospective investigator blinded observational study. Introduction: Influenza vaccine has been shown to be highly effective in...	12th July, 2008	Yong Loo Lin School of Medicine, National University of Singapore,	Ann Acad Med Singapore. 2008 Jun;37(6):465-5.
→View more research publications.

BioNews Results for Vaccination:
Rabies Vaccination Clinics	KKTV.com:  Jul 11 2008 5:25AM Matching: vaccination
For Patients With Asthma, Flu Vaccine Coverage Falls Short	American Family Physician:  Jul 10 2008 10:11AM Matching: vaccination
Merck Responds to Questions about Adverse Events Reported following Vaccination with GARDASIL	WebWire:  Jul 10 2008 4:31PM Matching: vaccination
Pneumococcal Vaccine Proves Very Effective After Only 2 Years in Norway	PSL Group:  Jul 9 2008 11:20PM Matching: vaccination
A cancer we can beat	Checkbiotech:  Jul 9 2008 12:27PM Matching: vaccination
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Vaccination Clinical Trials:
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases	Coronary Artery Diseases;   Myocardial Infarction;   Stable Angina
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440	Japanese Encephalitis
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age	Pneumococcal Diseases
Influenza Vaccination and Oral Anticoagulant Therapy	Anticoagulants;   Influenza Vaccines
Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department	High Risk for Serious Influenza;   High Risk for Pneumonia
→View more trials.

Vaccination Patents:
US Patent No.	Title
7388080	Selective inhibition of toll-like receptor-2
7390654	Avoidance of undesirable replication intermediates in plasmid propagation
7390871	Tumor antigen based on products of the tumor suppressor gene WT1
7390881	Recombinant therapeutic fusion proteins
7390884	Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease
→View more patents.

Companies working in the area of Vaccination from Bioportfolio's Biocorporate database :
Company Name
ABION GmbH ABION has developed an immunoassay technology ABICAP (Antibody Immuno Column for Analytical Processes), a new generation of immunoassays that is based on an immuno affinity column design. The...         View full profile
ALK Abello A/S ALK Abello develops, produces and distributes effective, innovative products for the diagnosis, prevention, relief of allergic symptoms and cure of allergies. ALK Abello's R&D activities... www.alk-abello.com/        View full profile
CEL-SCI Corporation CEL-SCI Corporation is involved in the research and development of certain drugs and vaccines. CEL-SCI's first product, MULTIKINE(TM), manufactured using the Company's proprietary cell...         View full profile
→View more Vaccination related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Vaccination scientists - we have details of around 7880 individuals working on Vaccination .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.